Nucleation and crystal growth in supersaturated solutions of a model drug.
about
The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism.Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.Characterization of ibuprofen microparticle and improvement of the dissolution.Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallizationReview: physical chemistry of solid dispersions.Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.Advancing in-vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model.The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility.Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors.A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution.Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.Probing the early stages of salt nucleation--experimental and theoretical investigations of sodium/potassium thiocyanate cluster anions.Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.Inhibition of solution crystal growth of ritonavir by cellulose polymers – factors influencing polymer effectiveness
P2860
Q31125399-3548E971-9C05-498E-9479-A7E4A8831920Q33958395-CD7407F1-6F9E-4DA9-8A84-E09ACD20AF80Q34323630-193C28FD-9D8E-47F3-BE77-4FC7A7DD8B5CQ35982999-0FA968B5-B888-4C2D-9C9D-63C923C2264CQ36009014-74E7657C-D448-4A2E-93D3-C0CE8A7F605AQ37643840-F253BE00-D9CD-4F8C-A8BE-76C2C74567F9Q37802897-948E3161-AA87-47CE-9A0B-3C17A164538EQ38619443-BE774899-9B4B-44B6-83F0-58402B024F3FQ38644728-32CBAA7A-4A3E-4E93-BD54-9741AB895574Q38856754-33606541-1A3E-4F7C-B205-F1E48A9FA005Q39729707-9E3FCF83-DDA5-400E-893E-8FD635735A0FQ41335984-F770F69B-4A63-4D0A-88AE-1F5E2882ED3DQ41545455-24A75452-F737-47BF-8B01-3490F483973DQ41968403-19C687D3-378A-4FB6-862F-5BF7339F64EEQ41972013-1AC1AC59-26F3-40E5-8D16-D9760A5199A1Q44513984-54172CB0-C9B0-42B7-82A2-47FB9C2820DFQ44936526-C80412F2-1BDC-4820-BCFE-9B6207ADF462Q46786139-D813C0A7-496B-4FCB-BFE2-3F874D04E17FQ47141833-0FC09D90-CE9B-4578-A664-DE2E4365A136Q48627689-9BD9CD4E-5D47-4E4E-B5CE-BA18DF905E7FQ57376538-3235AE4E-FAFD-4E12-B638-CAFDA47BD1B3
P2860
Nucleation and crystal growth in supersaturated solutions of a model drug.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Nucleation and crystal growth in supersaturated solutions of a model drug.
@ast
Nucleation and crystal growth in supersaturated solutions of a model drug.
@en
type
label
Nucleation and crystal growth in supersaturated solutions of a model drug.
@ast
Nucleation and crystal growth in supersaturated solutions of a model drug.
@en
prefLabel
Nucleation and crystal growth in supersaturated solutions of a model drug.
@ast
Nucleation and crystal growth in supersaturated solutions of a model drug.
@en
P2093
P1476
Nucleation and crystal growth in supersaturated solutions of a model drug.
@en
P2093
Jan Westergren
Lennart Lindfors
Sara Forssén
Ulf Olsson
P304
P356
10.1016/J.JCIS.2008.05.034
P407
P577
2008-05-27T00:00:00Z